[1]
Y.-B. Qi, “Vonoprazan-containing Dual and Triple Therapies are Non-inferior to Bismuth-quadruple Therapy for Helicobacter pylori Eradication: A Single-center, Prospective, Open-label, Real-World Study”, JGLD, vol. 34, no. 3, pp. 295–303, Sep. 2025.